Pfizer、Ibm和Microsoft支持Amicore以
Fitzsimmons said that the PenChart software provides a foundation for Amicore's first products, but the company plans to work with IBM to develop a secure application service provider (ASP) hosting service for the small physician market. It also will develop new healthcare applications with Microsoft based on Microsoft's ".Net" technology, which should be introduced into Microsoft operating systems in January 2002.
"The Microsoft .Net technology platform will enable physicians to practice medicine any time, any place, on any device," said David Lubinski, a healthcare general manager in the Microsoft enterprise sales and industry group, in a statement.
"We are pleased to work with IBM and Microsoft and believe that Amicore provides a complete technology solution for the practicing physician," added Pfizer senior vice president Peter Brandt.
The Amicore Practice Suite, based on the clinical workflow software developed by the PenChart, uses an electronic patient record and unifies the administrative, clinical and financial functions in the medical office, according to Amicore. The application utilizes wireless pen tablet PCs and runs on the Microsoft Windows platform. Amicore said that the Microsoft .Net technology would enable the applications to also run on other pen Tablet PCs or smart mobile devices.
A recent customer survey indicated the PenChart software almost entirely eliminated the cost of filing and retrieving paper medical records, according to Amicore. Survey respondents also said that PenChart significantly reduced the cost of ordering prescription refills and of transcription services by more than 80%.
"I've spent 10 years trying to bring information to the physician at the point of care because I knew it would improve care and decrease costs," said Fitzsimmons, who most recently was employed by Phyve Corp., another software company. "These three companies have the resources to achieve that goal."
Faraz Naqvi, co-manager of Dresdner RCM Global Healthcare Fund, notes that Pfizer is in a "no-lose situation" in the Amicore joint venture because it already has control over the new, small physician market. For IBM and Microsoft, Amicore is an entr閑 in a new market for their services.
In Wednesday trade on the New York Stock Exchange, shares of Pfizer rose 1.01 to close at 41.75 and IBM climbed 0.11 to close at 97.25. On the NASDAQ exchange, shares of Microsoft rose 0.95 to close at 55.51., 百拇医药
"The Microsoft .Net technology platform will enable physicians to practice medicine any time, any place, on any device," said David Lubinski, a healthcare general manager in the Microsoft enterprise sales and industry group, in a statement.
"We are pleased to work with IBM and Microsoft and believe that Amicore provides a complete technology solution for the practicing physician," added Pfizer senior vice president Peter Brandt.
The Amicore Practice Suite, based on the clinical workflow software developed by the PenChart, uses an electronic patient record and unifies the administrative, clinical and financial functions in the medical office, according to Amicore. The application utilizes wireless pen tablet PCs and runs on the Microsoft Windows platform. Amicore said that the Microsoft .Net technology would enable the applications to also run on other pen Tablet PCs or smart mobile devices.
A recent customer survey indicated the PenChart software almost entirely eliminated the cost of filing and retrieving paper medical records, according to Amicore. Survey respondents also said that PenChart significantly reduced the cost of ordering prescription refills and of transcription services by more than 80%.
"I've spent 10 years trying to bring information to the physician at the point of care because I knew it would improve care and decrease costs," said Fitzsimmons, who most recently was employed by Phyve Corp., another software company. "These three companies have the resources to achieve that goal."
Faraz Naqvi, co-manager of Dresdner RCM Global Healthcare Fund, notes that Pfizer is in a "no-lose situation" in the Amicore joint venture because it already has control over the new, small physician market. For IBM and Microsoft, Amicore is an entr閑 in a new market for their services.
In Wednesday trade on the New York Stock Exchange, shares of Pfizer rose 1.01 to close at 41.75 and IBM climbed 0.11 to close at 97.25. On the NASDAQ exchange, shares of Microsoft rose 0.95 to close at 55.51., 百拇医药